Stock comparison
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CTKB
Cytek Biosciences
Market cap
$517.86M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
| Strategy | CTKB | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 21F | 69B | MTD |
| Benjamin Graham | 35D | 65B | MTD |
| Philip Fisher | 30F | 63C | MTD |
| Peter Lynch | 22F | 66B | MTD |
| Joel Greenblatt | 0F | 68B | MTD |
| Charlie Munger | 21F | 74B | MTD |
| Terry Smith | 23F | 70B | MTD |
| Metric | CTKB | MTD |
|---|---|---|
| Market cap | $517.86M | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | - | 21.6x |
| ROIC (TTM) | -11.42% | 36.09% |
| Gross margin | 51.7% | 57.79% |
| Net margin | -36.25% | 21.4% |
| Revenue CAGR 5y | 12.02% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CTKB leads on
MTD leads on
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.